Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LIPG | Q9Y5X9 | 5/20 | 0.41 |
| ▸ | LPL | P06858 | 4/20 | 0.41 |
| ▸ | CSF1R | P07333 | 1/20 | 0.39 |
| ▸ | PRMT5 | O14744 | 1/20 | 0.32 |
| ▸ | WDR77 | Q9BQA1 | 1/20 | 0.32 |
| ▸ | PRKDC | P78527 | 1/20 | 0.31 |
| ▸ | IRAK4 | Q9NWZ3 | 1/20 | 0.31 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.30 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25950268 | 0.94 | CSF1R (0.41) | LIPGLPLCSF1RPRMT5WDR77 | |
| SCHEMBL25950308 | 0.86 | CSF1R (0.38) | LIPGLPLCSF1RPRMT5WDR77 | |
| SCHEMBL21191777 | 0.84 | LIPG (0.38) | LIPGLPLCSF1RPRMT5WDR77 | |
| SCHEMBL25952013 | 0.83 | LIPG (0.36) | LIPGLPLCSF1R | |
| SCHEMBL17057165 | 0.81 | ALOX5 (0.44) | CSF1RPRMT5WDR77PRKDC | |
| SCHEMBL25950284 | 0.81 | AHR (0.42) | PRKDC | |
| SCHEMBL21147931 | 0.80 | LIPG (0.49) | LIPGLPLPRMT5WDR77IRAK4 | |
| SCHEMBL18090451 | 0.80 | LIPG (0.49) | LIPGLPLCSF1RPRMT5WDR77 | |
| SCHEMBL23230612 | 0.80 | LIPG (0.51) | LIPGLPLCSF1RPRMT5WDR77 | |
| SCHEMBL15458630 | 0.79 | LIPG (0.50) | LIPGLPLPRMT5WDR77IRAK4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230247904-A1 | NOVEL COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME | LG CHEM, LTD. (KR) | 2023-08-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230247904-A1 | NOVEL COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME | NR2E3, CRY2, DRD1 | LIPG 4506/4885LPL 2824/4885CSF1R 1050/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.